Evidence map›Paper›PMID 36984837›Full record

ArticleMetabolites2023

Cuminaldehyde Effects in a MIA-Induced Experimental Model Osteoarthritis in Rat Knees.

Sebastião Vieira de Morais, Priscylla Gouveia Mendonça, Cleydlenne Costa Vasconcelos, Paloma Larissa Arruda Lopes, João Batista Santos Garcia, Natalia Tabosa Machado Calzerra, Thyago Moreira de Queiroz, Silvia Tereza de Jesus Rodrigues Moreira Lima, Gyl Eanes Barros Silva, Alberto Jorge Oliveira Lopes and 2 more

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Sebastião Vieira de MoraisBiological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís 65085-580, MA, Brazil.
Priscylla Gouveia MendonçaBiological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís 65085-580, MA, Brazil.ORCID 0000-0002-4905-8049
Cleydlenne Costa VasconcelosBiological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís 65085-580, MA, Brazil.
Paloma Larissa Arruda LopesBiological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís 65085-580, MA, Brazil.ORCID 0009-0007-1938-9553
João Batista Santos GarciaBiological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís 65085-580, MA, Brazil.ORCID 0000-0002-3597-6471
Natalia Tabosa Machado CalzerraDepartment of Physiology and Pharmacology, Federal University of Pernambuco, Av. Prof. Moraes Rego, 1235-Cidade Universitária, Recife 50670-901, PE, Brazil.
Thyago Moreira de QueirozLaboratory of Nutrition, Physical Activity and Phenotypic Plasticity, Federal University of Pernambuco, Av. Prof. Moraes Rego, 1235-Cidade Universitária, Recife 50670-901, PE, Brazil.ORCID 0000-0003-4183-7328
Silvia Tereza de Jesus Rodrigues Moreira LimaBiological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís 65085-580, MA, Brazil.
Gyl Eanes Barros SilvaBiological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís 65085-580, MA, Brazil.
Alberto Jorge Oliveira LopesFederal Institute of Science Education and Technology of Maranhão-Campus Monte Castelo, Chemistry Postgraduate Program, Av. Getúlio Vargas, 04-Monte Castelo, São Luís 65030-005, MA, Brazil.ORCID 0000-0001-5267-9500
Maria do Socorro de Sousa CartágenesBiological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís 65085-580, MA, Brazil.
Gerson Ricardo de Souza DominguesState University of Rio de Janeiro School of Medicine, Av. Prof. Manoel de Abreu, 444, Vila Isabel-Rio de Janeiro 20550-170, RJ, Brazil.
Universidade Federal do Maranhão · BRUniversidade Federal de Pernambuco · BRHospital Universitário da Universidade Federal do Maranhão · BRInstituto Federal do Maranhão · BRUniversidade do Estado do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is a chronic degenerative disease that has a significant global impact. It is associated with aging and characterized by widespread joint destruction. Cuminaldehyde is a biologically active component of essential oils that has shown promise in the treatment of nociceptive and inflammatory diseases. This study investigated the effects of cuminaldehyde on an experimental model of osteoarthritis induced in rat knees. Cuminaldehyde was found to be as effective as indomethacin in reducing pain in all evaluated tests, including forced walking, functional disability of weight distribution on the legs, and spontaneous pain in animals with osteoarthritis. The knees of animals treated with cuminaldehyde had significantly higher radiographic and histopathological scores than those of animals that did not receive the treatment. Cuminaldehyde also modulated the production of pro-inflammatory cytokines. In vitro assays showed that cuminaldehyde preferentially inhibits COX-2 enzyme activity. In silico studies demonstrated that cuminaldehyde has satisfactory energy affinity parameters with opioid receptors and COX-2. These findings suggest that cuminaldehyde's anti-inflammatory activity is multifactorial, acting through multiple pathways. Its nociceptive activity occurs via central and peripheral mechanisms. Cuminaldehyde modulates the immune response of the inflammatory process and may be considered a leading compound for the development of new anti-inflammatory and analgesic drugs.

Indexed as

biological activitymedicinal chemistrynatural productsnew drugs agents

Identifiers

PMID36984837
PMCPMC10056807
OpenAlexW4323569740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.